News & Updates

Finerenone CV benefit extends to wide spectrum of CKD patients with T2D: FIGARO-DKD

25 Sep 2021 by

The large, phase III FIGARO-DKD trial strengthen the evidence on cardiovascular benefit (CV) of the nonsteroidal mineralocorticoid receptor (MR) antagonist finerenone, in addition to its renal benefit, across a wide spectrum of patients with type 2 diabetes (T2D) and chronic kidney disease (CKD).

Finerenone CV benefit extends to wide spectrum of CKD patients with T2D: FIGARO-DKD

25 Sep 2021

Coding changes for type 2, 3–5 MI tied to decrease in hospitalizations for new ICD-10 type 1 MI

25 Sep 2021

The introduction of the International Classification of Disease (ICD)-10 codes for type 2 and types 3–5 myocardial infarction (MI) leads to a reduction in hospitalizations for ICD-10 codes now attributed to type 1 MI and correlates with changes in the observed characteristics and treatment patterns of these patients, according to a study.

Coding changes for type 2, 3–5 MI tied to decrease in hospitalizations for new ICD-10 type 1 MI

25 Sep 2021

Cost, convenience main barriers to colonoscopy screening for CRC

25 Sep 2021 by

Perceived barriers to healthcare, such as cost and inconvenience, discourage patients with positive faecal immunochemical test (FIT) results from undergoing follow-up colonoscopy for colorectal cancer (CRC) screening, according to a recent Singapore study.

Cost, convenience main barriers to colonoscopy screening for CRC

25 Sep 2021

Topical permethrin plus oral ivermectin effective against common scabies

25 Sep 2021

The combination of topical permethrin and oral ivermectin is an effective treatment for common scabies, a new study has found. However, post-scabetic itch seems to persist longer than has been previously thought, particularly in older adults.

Topical permethrin plus oral ivermectin effective against common scabies

25 Sep 2021

Mepolizumab benefits held up over time

25 Sep 2021 by

Beyond 1 year, the humanized monoclonal antibody mepolizumab maintained real-world efficacy and safety in patients with severe eosinophilic asthma in the REALITI-A cohort study, reports an expert at ERS 2021.

Mepolizumab benefits held up over time

25 Sep 2021

Adding cyclophosphamide to glucocorticoids confers no survival benefit in IPF

24 Sep 2021 by

Adding cyclophosphamide to glucocorticoid treatment in patients with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) was associated with a numerically increased risk of mortality, according to results of the phase III EXAFIP trial.

Adding cyclophosphamide to glucocorticoids confers no survival benefit in IPF

24 Sep 2021

Astegolimab suppresses asthma exacerbation

24 Sep 2021

Astegolimab, a human immunoglobulin G2 monoclonal antibody, can effectively and safely reduce asthma exacerbation rate, a recent study has found.

Astegolimab suppresses asthma exacerbation

24 Sep 2021

SARS-CoV-2 lurks in small airborne particles

24 Sep 2021 by

Investigations into the role of small aerosol particles in COVID-19 transmission suggest that SARS-CoV-2 may be an airborne hazard. A recent medRxiv preprint study from Singapore adds to this body of evidence.

SARS-CoV-2 lurks in small airborne particles

24 Sep 2021

Middle-aged gout patients at higher risk of cancer, mortality

24 Sep 2021

The risks of cancer and all-cause and cancer mortality are higher among middle-aged patients with gout than the general population, reveals a study.

Middle-aged gout patients at higher risk of cancer, mortality

24 Sep 2021

Vaping tied to more asthma symptoms, abnormal lung mechanics

24 Sep 2021 by

Use of e-cigarette or vaping appears to increase asthma symptoms and abnormal lung mechanics, suggesting potential adverse effects posed by this product, a study has shown. Young adults, tobacco smokers, and those with mental health conditions are more likely to engage in e-cigarette use.

Vaping tied to more asthma symptoms, abnormal lung mechanics

24 Sep 2021

News & Updates

Filter by Specialty:

Specialty:

Finerenone CV benefit extends to wide spectrum of CKD patients with T2D: FIGARO-DKD

Finerenone CV benefit extends to wide spectrum of CKD patients with T2D: FIGARO-DKD

Coding changes for type 2, 3–5 MI tied to decrease in hospitalizations for new ICD-10 type 1 MI

Coding changes for type 2, 3–5 MI tied to decrease in hospitalizations for new ICD-10 type 1 MI

Cost, convenience main barriers to colonoscopy screening for CRC

Cost, convenience main barriers to colonoscopy screening for CRC

Topical permethrin plus oral ivermectin effective against common scabies

Topical permethrin plus oral ivermectin effective against common scabies

Mepolizumab benefits held up over time

Mepolizumab benefits held up over time

Adding cyclophosphamide to glucocorticoids confers no survival benefit in IPF

Adding cyclophosphamide to glucocorticoids confers no survival benefit in IPF

Astegolimab suppresses asthma exacerbation

Astegolimab suppresses asthma exacerbation

SARS-CoV-2 lurks in small airborne particles

SARS-CoV-2 lurks in small airborne particles

Middle-aged gout patients at higher risk of cancer, mortality

Middle-aged gout patients at higher risk of cancer, mortality

Vaping tied to more asthma symptoms, abnormal lung mechanics

Vaping tied to more asthma symptoms, abnormal lung mechanics